Milestone for AI in science: Google AI generates cancer hypothesis later validated by scientists, says Sundar Pichai

In a significant development for AI in biomedical research, Google’s C2S-Scale 27B foundation model, developed in collaboration with Yale University and based on the Gemma framework, has successfully generated a novel hypothesis about cancer cell behaviour. This hypothesis was later experimentally validated in living human cells, marking an important step forward in the integration of artificial intelligence with laboratory science.

Google CEO Sundar Pichai hailed the development as a major advance in the partnership between AI and laboratory science. He emphasised that the discovery could guide future preclinical and clinical research, potentially revealing new pathways for cancer therapy.